New dual therapy targets Hard-to-Treat gut cancers
Disease control
Recruiting now
This early-stage study tests a new treatment called DISP-10 for people with advanced cancers of the stomach, esophagus, or colon that have spread. DISP-10 combines a virus that attacks cancer cells with a special immune cell therapy (CAR T-cells) that targets a protein on those c…
Phase: PHASE1 • Sponsor: Dispatch Biotherapeutics • Aim: Disease control
Last updated May 04, 2026 16:19 UTC